Azaheterocyclic compounds as kinase inhibitors

US8859581B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Timo Heinrich · Groß-Umstadt, DE
• Andree Blaukat · Heilbad Heiligenstadt, DE
• Wolfgang Staehle · Ingelheim am Rhein, DE
• Hartmut Greiner · Darmstadt, DE
• Maria Kordowicz · Griesheim, DE

Key dates

• Filing date: Mar 30, 2006
• Grant date: Oct 14, 2014
• Expiry date: Dec 2, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compounds of the formula (I), to the preparation and use thereof for the preparation of a medicament for the treatment of diseases, in particular tumors and/or diseases in the development or course of which kinases are involved.